PMA device
Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear
Menicon Co, Ltd. · Lens, Contact, Orthokeratology, Overnight (NUU, Class III) · First FDA decision Nov 6, 2019, newest Aug 2, 2022Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
10
Naming "Z Night"
MAUDE reports
0
Brand "Z Night", since 2015
PubMed studies
0
Mentioning "Z Night"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear; ACUVUE® Abiliti Overnight and ACUVUE® Abiliti OverniPMA supplement
P990018-S008 · Decided Aug 2, 2022 · 176 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
P990018-S005 · Decided Nov 6, 2019 · 343 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Z Night", any status and sponsor, newest update first.
- Influence of Pulse Electromagnetic Field Therapy on Myocardial IschemiaPivotal-lookingRecruiting
Mayo ClinicAcademic, hospital or other
NCT05111288 · 120 participants (planned) · Start May 18, 2022 · Primary completion Jun 2027
Device: Pulsed electromagnetic field therapy (PEMF); Inactive Pulsed electromagnetic field therapy (PEMF) · For: Coronary Artery Disease; Myocardial Infarction
Sites: Scottsdale, Arizona; Rochester, Minnesota
The Hong Kong Polytechnic UniversityAcademic, hospital or other
NCT04293328 · 30 participants (planned) · Start Jul 7, 2020 · Primary completion Jun 2023
Device: orthokeratology; Menicon Progent A+B · For: Myopic Progression
Sites: Kowloon, Hong Kong
The Hong Kong Polytechnic UniversityAcademic, hospital or other
NCT04295707 · 80 participants (planned) · Start Mar 11, 2020 · Primary completion Jun 2023
Device: orthokeratology; Menicon Progent A+B · For: Myopic Progression
Sites: Kowloon, Hong Kong
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Z Night", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NUU
40 reports: 3 malfunction, 37 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Z Night"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NUU.
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactEuclid Vision Corporation · PMA 2026
- Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping TreatmentBausch & Lomb · PMA 2025
- Paragon Z CRT (tisilfocon A) and Paragon Z CRT Dual Axis (tisilfocon A) Rigid Gas Permeable Contact lenses in blue tintCooperVision, Inc. · PMA 2019
- Jsz Orthokeratology (Oprifocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2016
- DilightTM (roflufocon E) Overnight Orthokeratology Contact LensTianjin MasterVision Technology Co., Ltd. · PMA 2026
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses IIContamac, Ltd. · PMA 2026
- ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia ManagementMenicon Co, Ltd. · PMA 2021
- Orthokeratology (tisilfocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.